These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Stupor and fast activity on electroencephalography in a child treated with valproate. Mastrangelo M; Mariani R; Spalice A; Rocchi V; Iannetti P Pediatr Neurol; 2009 Jul; 41(1):53-6. PubMed ID: 19520277 [TBL] [Abstract][Full Text] [Related]
7. Visual field defect during therapy with valproic-acid. Tilz C; Wang-Tilz Y; Jünemann A; Stefan H; Michelson G Eur J Neurol; 2007 Aug; 14(8):929-32. PubMed ID: 17662017 [TBL] [Abstract][Full Text] [Related]
9. Neurostabilizers for migraine prevention. From dosage administration to patient expectations. Wright W Adv Nurse Pract; 2007 Feb; 15(2):52-4, 56-8, 85. PubMed ID: 19998927 [No Abstract] [Full Text] [Related]
10. Adverse effects of valproate. Schmidt D Epilepsia; 1984; 25 Suppl 1():S44-9. PubMed ID: 6425046 [No Abstract] [Full Text] [Related]
11. Valproate prescribing trends for non-epilepsy indications in women of reproductive age warrants effective measures and increased surveillance. Kaplan YC; Abdelkader N Seizure; 2016 Aug; 40():13-4. PubMed ID: 27289305 [No Abstract] [Full Text] [Related]
12. Hematological effects of valproate in psychiatric patients: what are the risk factors? Vasudev K; Keown P; Gibb I; McAllister-Williams RH J Clin Psychopharmacol; 2010 Jun; 30(3):282-5. PubMed ID: 20473063 [TBL] [Abstract][Full Text] [Related]
19. Massive oxidative haemolysis and renal failure caused by high dose vitamin C. Rees MJ; Strach MC; Burbury K; Phillips KA Med J Aust; 2018 Sep; 209(6):248-249. PubMed ID: 30208815 [No Abstract] [Full Text] [Related]
20. Successful reintroduction of valproic acid after the occurrence of pancytopenia. Stewart JT Am J Geriatr Pharmacother; 2011 Oct; 9(5):351-3. PubMed ID: 21962938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]